HIV resistance testing helps healthcare professionals identify genetic changes in the human immunodeficiency virus that may reduce the effectiveness of certain antiretroviral medicines. Before starting treatment, this testing can provide useful information for selecting an appropriate combination of medications. Although many people with HIV respond well to recommended treatment, some may have drug-resistant virus because of transmitted resistance or previous exposure to antiretroviral medicines. Understanding the purpose, process, and interpretation of resistance testing can help individuals participate in informed treatment decisions. This article explains common testing methods, factors influencing results, and the role of resistance testing in HIV care.
HIV treatment has advanced considerably, and antiretroviral therapy (ART) can help people with HIV achieve and maintain viral suppression. However, some HIV strains contain genetic changes that make particular medicines less effective. HIV resistance testing can help healthcare professionals identify these changes and select treatment options suited to an individual's circumstances. The decision to perform testing depends on clinical guidelines, treatment history, and the person's health status.
HIV resistance testing examines the virus's genetic material to identify mutations associated with reduced susceptibility to antiretroviral medicines. These mutations can affect how well specific drugs prevent HIV from multiplying. Testing is particularly useful when choosing an initial treatment regimen, especially when transmitted drug resistance is suspected or treatment history raises concerns.
Healthcare professionals may use different testing methods depending on the clinical situation.
Genotypic resistance testing: Identifies genetic mutations associated with resistance to particular HIV medicines. It is commonly used when selecting or changing treatment.
Phenotypic resistance testing: Measures how effectively HIV grows in the presence of different antiretroviral medicines. It may be useful in selected cases involving complex resistance patterns.
Baseline testing: Resistance testing is generally recommended when a person is newly diagnosed and preparing to begin HIV treatment, although the specific recommendations depend on the clinical circumstances.
Integrase resistance testing: May be considered when resistance to integrase inhibitors is suspected or when particular treatment histories make this information relevant.
Treatment should not automatically be delayed while waiting for resistance test results. Depending on the circumstances, healthcare professionals may begin an appropriate initial regimen and adjust it when the results become available.
Resistance test results help healthcare professionals understand which medicines are likely to remain effective. The results are interpreted alongside viral load measurements, medical history, other medications, potential drug interactions, and relevant health conditions.
Several factors influence how testing contributes to treatment decisions.
Selecting medicines: Results can help clinicians avoid drugs that are unlikely to work effectively because of identified resistance mutations.
Understanding transmitted resistance: Some individuals acquire HIV that already carries drug-resistant mutations, even if they have never taken HIV medication.
Reviewing previous treatment: Earlier exposure to antiretroviral medicines and previous treatment failures can influence which resistance tests are appropriate.
Interpreting viral load: HIV viral load testing measures the amount of virus in the blood, whereas resistance testing examines whether genetic changes may affect drug effectiveness. These tests provide different but complementary information.
Supporting ongoing care: If treatment does not suppress HIV as expected, clinicians may evaluate adherence, drug interactions, resistance, and other possible explanations before modifying the regimen.
Resistance testing has limitations. Some mutations may not be detected, particularly when resistant virus is present at low levels. Results must therefore be interpreted by a qualified healthcare professional rather than used independently to select or stop medication.
Understanding HIV resistance testing can help individuals recognize why treatment decisions are personalized. Testing provides important information about potential drug resistance, while viral load monitoring helps assess how well treatment controls the virus over time. Following prescribed therapy, attending medical appointments, and discussing difficulties with medication use can support effective HIV management.